Page last updated: 2024-12-06
4-nitroso-n,n-diethylaniline
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
4-nitroso-N,N-diethylaniline: C-nitroso compound [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 67115 |
| SCHEMBL ID | 146443 |
| MeSH ID | M0060714 |
Synonyms (36)
| Synonym |
|---|
| 4-nitroso-n,n-diethylaniline |
| p-nitrosodiethylaniline |
| diethylnitrosoaniline |
| brn 2804428 |
| aniline, n,n-diethyl-p-nitroso- |
| n,n-diethyl-4-nitrosobenzenamine |
| 4-diethylaminonitrosobenzene |
| n,n-diethyl-4-nitrosoaniline |
| benzenamine, n,n-diethyl-4-nitroso- |
| einecs 204-379-5 |
| nsc 5418 |
| ai3-15392 |
| ccris 3087 |
| 120-22-9 |
| nsc5418 |
| aniline,n-diethyl-p-nitroso- |
| p-nitroso-n,n-diethylaniline |
| n,n-diethyl-p-nitrosoaniline |
| nsc-5418 |
| benzenamine,n-diethyl-4-nitroso- |
| N0260 |
| AKOS002318224 |
| 4-12-00-01559 (beilstein handbook reference) |
| 5qx2as44rv , |
| unii-5qx2as44rv |
| para-nitroso-n,n-diethylaniline |
| FT-0619299 |
| F3099-5847 |
| SCHEMBL146443 |
| DTXSID3059507 |
| diethyl-p-nitrosoaniline |
| W-109442 |
| mfcd00002064 |
| p-nitrosodiathylanilin |
| D91662 |
| BS-43856 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (6)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 12.67
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.67) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 6 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||